It’s been a tale of two health insurance shares on the ASX this week
The post How does the Medibank (ASX:MPL) earnings result compare to NIB? appeared first on The Motley Fool Australia. –
The Medibank Private Ltd (ASX: MPL) earnings result was one to watch this week. The Aussie private health insurer released its full-year results for the year ended 30 June 2021 (FY21) and had an instant share price impact.
The Medibank share price jumped 2% higher on Wednesday morning following the release before closing the day 0.6% higher at $3.57 per share.
As one of the biggest weeks of the August earnings season comes to a close, let’s compare the Medibank result against that of rival insurer, NIB Holdings Limited (ASX: NHF).
How does the Medibank earnings result compare to NIB?
In case you missed it, some of the big takeaways from Medibank’s earnings result on Wednesday were:
Revenue up 1.99% on the prior corresponding period (pcp) to $6.9 billion
Net profit after tax (NPAT) up 39.8% on pcp to $441 million
It’s worth noting the surge in profits was helped by a 4,900% increase in net investment income throughout the year.
In contrast, the NIB share price sank 6.3% lower on Monday following its half-year earnings update. The Aussie private health insurer reported that revenue was down 2.9% on pcp to $2.6 billion with expense claims up 2.5% on pcp to $2 billion.
NPAT came in 84.5% higher on pcp at $160.5 million, while NIB announced a 14 cents per share final dividend, fully franked.
There’s no doubt that the COVID-19 pandemic continues to weigh on earnings across the ASX but particularly for the Aussie health insurers.
The Medibank earnings result sent the company’s shares soaring while the same can’t be said for NIB. NIB reported significantly weakened international inbound and travel earnings as a result of the COVID-19 pandemic.
The group has also put aside $34 million in provisions to catch up on deferred claims in relation to COVID-19.
The NIB share price has climbed 10% higher in 2021 while Medibank shares are up 16.1% year to date. While shares in both insurers have seen double-digit gains, it does mean that Medibank is outperforming the S&P/ASX 200 Index (ASX: XJO) while NIB is not.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of August 16th 2021
How did the Medibank (ASX:MPL) share price respond last earnings season?
NIB and Ampol share prices fall, new record for Domino’s. Scott Phillips on Nine’s Late News
Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.